PresentationCytosolic Peptide Stability to Antigen N-Terminal Dibasic Peptides: Coupling Cutting Edge: HLA-B27 Acquires Many

Ag presentation by MHC class I is a highly inefficient process because cytosolic peptidases destroy most peptides after proteasomal generation. Various mechanisms shape the MHC class I peptidome. We define a new one: intracellular peptide stability. Peptides with two N-terminal basic amino acids are more stable than other peptides. Such peptides should be overrepresented in the peptidome of MHC class I-associated peptides. HLA-B27 binding peptides use anchor residue R at P2 and, although most amino acids are allowed, particular amino acids are overrepresented at P1, including R and K. We show that such N-terminal dibasic peptides are indeed more efficiently presented by HLA-B27. This suggests that HLA-B27 can present peptides from Ags present in fewer copies than required for successful peptide generation for other MHC class I molecules. The Journal of Immunology, 2006, 176: 2697–2701.

[1]  P. Kloetzel,et al.  Modeling the MHC class I pathway by combining predictions of proteasomal cleavage,TAP transport and MHC class I binding , 2005, Cellular and Molecular Life Sciences CMLS.

[2]  M. Vázquez,et al.  HLA-B27: a registry of constitutive peptide ligands. , 2004, Tissue antigens.

[3]  Jacques Neefjes,et al.  A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. , 2004, Immunity.

[4]  W. Saenger,et al.  Thermodynamic and Structural Analysis of Peptide- and Allele-dependent Properties of Two HLA-B27 Subtypes Exhibiting Differential Disease Association* , 2004, Journal of Biological Chemistry.

[5]  J. Yewdell,et al.  Making sense of mass destruction: quantitating MHC class I antigen presentation , 2003, Nature Reviews Immunology.

[6]  Shu-Bing Qian,et al.  Quantitating protein synthesis, degradation, and endogenous antigen processing. , 2003, Immunity.

[7]  J. Fernández-Morera,et al.  Association of ankylosing spondylitis with HLA-B*1403 in a West African population. , 2002, Arthritis and rheumatism.

[8]  A. Rickinson,et al.  Processing of a Multiple Membrane Spanning Epstein-Barr Virus Protein for Cd8+T Cell Recognition Reveals a Proteasome-Dependent, Transporter Associated with Antigen Processing–Independent Pathway , 2001, The Journal of experimental medicine.

[9]  P. Roholl,et al.  A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway. , 2001, The Journal of general virology.

[10]  Todd M. Allen,et al.  Gorillas with Spondyloarthropathies Express an MHC Class I Molecule with Only Limited Sequence Similarity to HLA-B27 that Binds Peptides with Arginine at P21 , 2001, The Journal of Immunology.

[11]  A. McMichael,et al.  Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. , 1999, Journal of immunology.

[12]  Martin A. Nowak,et al.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.

[13]  K. Tokunaga,et al.  Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket. , 1995, Arthritis and rheumatism.

[14]  K. Parker,et al.  The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor residues. , 1994, The Journal of biological chemistry.

[15]  Tae-Hwan Kim,et al.  Pathogenesis of ankylosing spondylitis and reactive arthritis , 1994, Current opinion in rheumatology.

[16]  Dean R. Madden,et al.  The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.

[17]  D. R. Madden,et al.  Identification of self peptides bound to purified HLA-B27 , 1991, Nature.

[18]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[19]  J. P. Durand,et al.  Studies of HLA-B27-associated disease. , 1988, The American journal of medicine.

[20]  H. Ploegh,et al.  Allele and locus‐specific differences in cell surface expression and the association of HLA class I heavy chain with β2‐microglobulin: differential effects of inhibition of glycosylation on class I subunit association , 1988, European journal of immunology.

[21]  G. Riethmüller,et al.  Complete sequence of HLA-B27 cDNA identified through the characterization of structural markers unique to the HLA-A, -B, and -C allelic series. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Kees Jalink,et al.  Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. , 2003, Immunity.

[23]  A. Goldberg,et al.  Protein degradation and the generation of MHC class I-presented peptides. , 2002, Advances in immunology.

[24]  K. Tokunaga,et al.  Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies. , 1999, Arthritis and rheumatism.